Rituximab shows promise for treating rare form of MG
The drug rituximab may bring long-term relief for patients with MuSK-MG, a rare form of myasthenia gravis.
The drug rituximab may bring long-term relief for patients with MuSK-MG, a rare form of myasthenia gravis.
Efgartigimod may help people with MG not only by reducing harmful antibodies but also by promoting immune balance.
While many YouTube videos about myasthenia gravis (MG) have moderate-to-high quality information, fewer are truly useful.
Efgartigimod restored muscle strength and helped rebalance immune cell numbers in mice with myasthenia gravis.
Though they have similar long-term outcomes, African American and Hispanic patients with MG have more severe disease than other groups.